Clinical reference
Antiemetic · 5-HT3 receptor antagonist · Oncology, Hematology, Pediatrics, Emergency Medicine, Anesthesiology, Gastroenterology
Ondansetron is a selective 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting associated with chemotherapy, radiation therapy, surgery, and acute gastroenteritis. Injection: 2 mg/mL (2, 20 mL); single-dose vials are preservative free and multidose vials contain parabens. Tablets: 4, 8, 24 mg. Orally disintegrating tablets (ODT): 4, 8…